Inside Miami’s Longevity & Skincare Summit: A Look at the Future of Skin Health
At the Innocos Conference on Longevity in Skincare, I explored how biomarkers, AI, and regenerative medicine are shaping the future of skin health. With longevity-based skincare innovation on the rise, how do we balance scientific validation with industry growth? Read my key takeaways from Miami.
The Next Frontier in Longevity: Highlights from the Hevolution Summit 2025
The Hevolution Summit 2025 in Riyadh brought together global experts to discuss the future of longevity, investment, and healthcare innovation. With Saudi Arabia's Vision 2030 healthcare plan, could the Kingdom become a leader in biomarker-driven longevity regulation? Explore key insights from the event, including breakthroughs in biotech, investment trends, and the challenges ahead.
Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science
Biomarkers are transforming longevity science, offering a way to validate interventions, track biological aging, and shape future healthcare policies. In this interview, Martin O’Dea discusses the latest advancements in biomarker science, the role of AI-driven diagnostics, and the path toward regulatory acceptance. Watch now to explore the future of aging research.
Biomarkers: The Key to Unlocking Healthy Longevity
Since measurable biomarkers are essential for tracking biological aging, assessing disease risk, and validating longevity interventions, they are shaping the future of healthcare. In this article, I explore the challenges of biomarker standardization, recent advances in proteomics, and how biomarker-driven regulation could transform aging research.
Michael Ringel on Gaps in Aging Science, Public Engagement, and Advancing Longevity
In this exclusive interview, Michael Ringel, MD at BCG, discusses two of Richard Barker’s '10 Wicked Issues in Healthy Longevity.' Discover key insights into the gaps in aging science, the importance of public engagement, and the economic opportunities tied to advancing healthspan. A must-watch for anyone invested in the future of longevity.
Bridging Gaps in Healthy Longevity: Insights from the JPMorgan Conference
The annual JPMorgan Health Conference provides a unique opportunity to gauge the state of life sciences and healthcare innovation. This year, key gaps in AI adoption and prevention-focused longevity therapies stood out, alongside promising discussions on advancing healthy aging. Discover insights from the event, the rise of GLP-1 therapies, and strategies to bridge critical gaps in longevity science.
Tina Woods on Systemic Change and the Future of Longevity
Richard Barker and Tina Woods discuss systemic challenges in healthy aging, the exposomics' potential, the relaunch of the International Institute of Longevity, and a new Exposome Prize.
End of 2024: Reflecting on Progress and Looking Ahead to 2025
A race against time: Reflecting on progress in healthy longevity and the urgent need for breakthroughs as we look ahead to 2025.
Uncovering Hidden Patterns: AI's Impact in Bogotá and London
Exploring the intersection of data and innovation: How AI uncovers hidden patterns in healthcare and beyond, from Bogotá to London.
GLP-1 Agonists: Our ChatGPT Moment in Preventive Medicine and Healthy Longevity
Discover how GLP-1 agonists, like Ozempic, are transforming preventive medicine and healthy longevity. Learn about their impact on weight loss, diabetes management, and reducing the risk of cardiovascular, kidney, and neurodegenerative diseases. Explore why this breakthrough is being hailed as our 'ChatGPT moment' in healthcare.
The Imperative of Female Longevity
Explore the imperative of female longevity and the critical role of women's health research. Delve into the impact of menopause and estrogen on aging, discover groundbreaking findings from the Dublin Longevity Summit, and learn how advancements in fertility preservation and anti-aging treatments are set to transform women's healthspan.
Understanding Polygenic Risk Scores for Advanced Precision Prevention
Your genes are not your destiny, but they do hold vital clues to your future. Discover how polygenic risk scores (PRS) are revolutionizing precision prevention by analyzing genetic mutations to predict disease risk. From breast cancer to cardiovascular disease, learn about the latest advancements and challenges in genetic testing and how it can guide more intensive screening and personalized health strategies. Explore the implications of PRS technology and its potential to transform healthcare systems.
Surveying The Explosion in New Healthy Longevity Clinics
Explore the rise of healthy longevity clinics with Prof Richard Barker’s expert insights.
Reflecting on 2023 and Charting the Course for 2024
Explore the global rise of healthy longevity in 2023 and what lies ahead in 2024. Prof Richard Barker discusses key trends, scientific advancements, and the future of healthspan programs.
Exploring Healthspan Opportunities and Challenges in Lithuania with Prof Richard Barker
Discover the latest insights from Prof Richard Barker on healthspan opportunities and challenges in Lithuania. Learn about key takeaways from his visits and discussions on precision prevention and innovative therapies.
Speaking at the NY Founders Forum: Precision Medicine, Longevity Science, and AI
Prof Richard Barker shares insights from the NY Founders Forum on precision medicine, longevity science, and AI. Learn about key discussions with industry leaders and innovative healthspan technologies.
Artificial Intelligence in the Global Spotlight: Opportunities and Risks
Explore Prof Richard Barker’s insights on AI in healthcare from the Bletchley Park Global Summit. Learn about AI’s benefits for healthy longevity, regulatory considerations, and the future of precision medicine.
The Role Of Genomics In Healthy Longevity
Discover how genomics is revolutionizing healthy longevity. Prof Richard Barker explores disease predisposition, early detection, and drug discovery through genomic insights, and discusses the future of personalized healthspan improvement.